Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Nurx vs Push Health

Nurx costs $771 less a month, and both sell semaglutide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Nurx logo

Nurx

4.8
★★☆☆☆2.4/5
Visit Nurx →
VS
Push Health logo

Push Health

5.6
★★★☆☆2.8/5

Best for: semaglutide from $950/month

Visit Push Health →

If you are choosing between Nurx and Push Health, the first difference is cost: Nurx is $771 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Push Health leads our six-part score, 5.6 to 4.8.

Nurx vs Push Health price

Nurx is the cheaper way in: $179 a month against $950 a month at Push Health. That is $771 less each month (81% lower), or about $9,252 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Nurx ($179 a month vs $950 a month).

Medications and formats

Both sell semaglutide; only Nurx lists tirzepatide.

On format, Nurx prices compounded injections, while Push Health prices brand-name pens.

If you want the FDA-approved brand rather than a compounded version, Push Health is the only one of the two with a brand-name price.

Where each one treats patients

Neither Nurx nor Push Health publishes the states it serves, so enter your state at the very start of each sign-up.

Pricing

Nurx

StartingCompounded
$179/mo
semaglutide

Range up to $299/mo

StartingCompounded
$179/mo
tirzepatide

Range up to $299/mo

Push Health

PreliminaryBrand-name
$950/mo
semaglutide

Ozempic / brand

What each price covers

Nurx is silent on shipping, lab work and coaching.

Push Health does not say what its price includes.

Nurx

Covered by the monthly price

Medication

Charged on top

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

Push Health

Inclusions not disclosed.

Where each one scores higher

Overall, Push Health scores 5.6 and Nurx 4.8 out of 10.

Nurx is stronger on effectiveness (10.0 vs 9.0).

Push Health is stronger on value (5.3 vs 3.0) and support (5.0 vs 0.0).

User experience, trust & safety and accessibility are within half a point.

How we score

Nurx

4.8/10

Overall

Push Health

5.6/10

Value25%

3.0A
vs
B
5.3

Effectiveness25%

10.0A
vs
B
9.0

User Experience15%

3.0A
vs
B
3.0

Trust & Safety15%

4.0A
vs
B
4.0

Accessibility10%

5.0A
vs
B
5.0

Support10%

0.0A
vs
B
5.0

FDA warning letters

Neither Nurx nor Push Health has an FDA warning letter on record with us.

Features & Coverage

FeatureNurxPush Health
Starting Price✓$179/mo$950/mo
Features3 features✓5 features
States AvailableNot disclosedNot disclosed
Compounded✓ Yes—
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Nurx

Nurx is an established women's telehealth brand running tiered GLP-1 weight loss programs.

Read our full Nurx review →

About Push Health

A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.

Read our full Push Health review →

Pros & Cons

Nurx

What we like

  • We found no FDA warning letters issued to Nurx

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Not included in the monthly price: medication, clinician visits
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Push Health

What we like

  • Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
  • We found no FDA warning letters issued to Push Health

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Our Verdict

Winner: Push Health

Push Health wins this one, 5.6 to 4.8, above all for semaglutide from $950/month. Nurx undercuts it by $771 a month, so if the monthly bill is what decides it, Nurx is the pick.

Choose Nurx if…

You want the lower starting price and an opening price near $179 a month.

Choose Push Health if…

You want semaglutide from $950/month and an opening price near $950 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.3

RNK Health

An oral route if you will not self-inject

9.2

He & She MD

Starting below a standard dose, with microdose tiers

5.9

Wellorithm

Compounded semaglutide at $247/month

Nurx vs Push Health: FAQ

Nurx. It starts at $179 a month; Push Health starts at $950 a month, $771 more per month.
Yes, both sell semaglutide. Nurx adds tirzepatide.
Nurx does not publish where it ships; Push Health does not publish where it ships. Confirm your state before paying.
Nurx and Push Health describe their inclusions differently; see the table above.
Nurx has none. Push Health has none.
No. Neither Nurx nor Push Health pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.